IT201700050994A1 - Uso di una Composizione comprendente 7-Idrossimatairesinolo - Google Patents

Uso di una Composizione comprendente 7-Idrossimatairesinolo

Info

Publication number
IT201700050994A1
IT201700050994A1 IT102017000050994A IT201700050994A IT201700050994A1 IT 201700050994 A1 IT201700050994 A1 IT 201700050994A1 IT 102017000050994 A IT102017000050994 A IT 102017000050994A IT 201700050994 A IT201700050994 A IT 201700050994A IT 201700050994 A1 IT201700050994 A1 IT 201700050994A1
Authority
IT
Italy
Prior art keywords
salinol
hydroxymato
composition
Prior art date
Application number
IT102017000050994A
Other languages
English (en)
Inventor
Barbara Pacchetti
Fabio Blandini
Francesca Siani
Original Assignee
Linnea Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Linnea Sa filed Critical Linnea Sa
Priority to IT102017000050994A priority Critical patent/IT201700050994A1/it
Priority to PCT/EP2018/061960 priority patent/WO2018206621A1/en
Priority to EP18722556.0A priority patent/EP3621608B1/en
Priority to ES18722556T priority patent/ES2928256T3/es
Priority to CA3061016A priority patent/CA3061016A1/en
Priority to AU2018265321A priority patent/AU2018265321B2/en
Priority to US16/611,420 priority patent/US11590101B2/en
Publication of IT201700050994A1 publication Critical patent/IT201700050994A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IT102017000050994A 2017-05-11 2017-05-11 Uso di una Composizione comprendente 7-Idrossimatairesinolo IT201700050994A1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT102017000050994A IT201700050994A1 (it) 2017-05-11 2017-05-11 Uso di una Composizione comprendente 7-Idrossimatairesinolo
PCT/EP2018/061960 WO2018206621A1 (en) 2017-05-11 2018-05-09 Use of a composition comprising 7-hydroxymatairesinol
EP18722556.0A EP3621608B1 (en) 2017-05-11 2018-05-09 Composition comprising 7-hydroxymatairesinol
ES18722556T ES2928256T3 (es) 2017-05-11 2018-05-09 Composición que comprende 7-hidroximatairesinol
CA3061016A CA3061016A1 (en) 2017-05-11 2018-05-09 Use of a composition comprising 7-hydroxymatairesinol
AU2018265321A AU2018265321B2 (en) 2017-05-11 2018-05-09 Use of a composition comprising 7-hydroxymatairesinol
US16/611,420 US11590101B2 (en) 2017-05-11 2018-05-09 Use of a composition comprising 7-hydroxymatairesinol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000050994A IT201700050994A1 (it) 2017-05-11 2017-05-11 Uso di una Composizione comprendente 7-Idrossimatairesinolo

Publications (1)

Publication Number Publication Date
IT201700050994A1 true IT201700050994A1 (it) 2018-11-11

Family

ID=60294018

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000050994A IT201700050994A1 (it) 2017-05-11 2017-05-11 Uso di una Composizione comprendente 7-Idrossimatairesinolo

Country Status (7)

Country Link
US (1) US11590101B2 (it)
EP (1) EP3621608B1 (it)
AU (1) AU2018265321B2 (it)
CA (1) CA3061016A1 (it)
ES (1) ES2928256T3 (it)
IT (1) IT201700050994A1 (it)
WO (1) WO2018206621A1 (it)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014083171A1 (en) * 2012-11-30 2014-06-05 Harmonic Pharma Natural compounds for use in the treatment of beta-2 adrenergic receptor related diseases
US20140308379A1 (en) * 2012-11-20 2014-10-16 The Trustees Of The University Of Pennsylvania Use of flaxseed and flaxseed derivatives for treatment of neurological disorders and viral diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451849B1 (en) 1999-03-30 2002-09-17 Hormos Nutraceutical Oy Ltd. Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol
US7008666B2 (en) * 2001-11-26 2006-03-07 Hormos Nutraceutical Oy Ltd. Method of inhibiting overactivity of phagocytes or lymphocytes in an individual
JP2008526819A (ja) 2005-01-10 2008-07-24 ホルモス メディカル リミテッド エストロゲン欠乏に関連する症状を予防または改善するための組成物を製造するためのリグナンの使用
AU2015261470A1 (en) 2014-05-15 2016-10-27 Linnea S.A. Composition comprising 7-hydroxymatairesinol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140308379A1 (en) * 2012-11-20 2014-10-16 The Trustees Of The University Of Pennsylvania Use of flaxseed and flaxseed derivatives for treatment of neurological disorders and viral diseases
WO2014083171A1 (en) * 2012-11-30 2014-06-05 Harmonic Pharma Natural compounds for use in the treatment of beta-2 adrenergic receptor related diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TOURANDOKHT BALUCHNEJADMOJARAD ET AL: "Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress", BIOMEDICINE AND PHARMACOTHERAPY., vol. 88, 1 April 2017 (2017-04-01), FR, pages 754 - 761, XP055456470, ISSN: 0753-3322, DOI: 10.1016/j.biopha.2017.01.123 *

Also Published As

Publication number Publication date
AU2018265321B2 (en) 2023-11-02
US20200170996A1 (en) 2020-06-04
CA3061016A1 (en) 2018-11-15
US11590101B2 (en) 2023-02-28
WO2018206621A1 (en) 2018-11-15
AU2018265321A1 (en) 2019-11-28
EP3621608B1 (en) 2022-07-20
EP3621608A1 (en) 2020-03-18
ES2928256T3 (es) 2022-11-16

Similar Documents

Publication Publication Date Title
DK3688162T3 (da) Formuleringer
DK3697376T3 (da) Sammensætning
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
BR112016020199A2 (pt) Composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
DK3416996T3 (da) Hærdelig sammensætning
BR112016026046A2 (pt) Uso de compostos de tienotriazolodiazepina
ES2970393T3 (es) Cemento dental
DK3651736T3 (da) Langtidsvirkende formuleringer
MA43731A (fr) Piston auto-compensateur
CL2015002803A1 (es) Una composición no nematicida y uso de los mismos
DK3328395T3 (da) Ny brug af dextransulfat
DK3595667T3 (da) Farmaceutiske sammensætninger omfattende en jak-hæmmer
DK3641719T3 (da) Dental klæber
KR20180085013A (ko) 접착제 조성물
DK3459354T3 (da) Glyceridsammensætning
DK3609464T3 (da) Xanthohumolbaserede sammensætninger
DK3840596T3 (da) Sammensætning
ES1209313Y (es) Composicion liofilizada
ITUA20161994A1 (it) Uso degli inibitori ddx3 come agenti anti-iperproliferativi
IT201700050994A1 (it) Uso di una Composizione comprendente 7-Idrossimatairesinolo
ITUA20162588A1 (it) Uso di una composizione comprendente acido alfa-lipoico.
DK3414211T3 (da) Gipssammensætning
DK3434403T3 (da) Arbejdsstation
IT201700006360A1 (it) Composizione per uso oftalmico
IT201700064228A1 (it) Riduttore